Bethesda, MD (July 9, 2025)—The National Foundation for Infectious Diseases (NFID) is pleased to announce the appointment of Wilbur H. Chen, MD, MS (University of Maryland School of Medicine) and Audrey M. Stevenson, PhD, MPH, FNP-BC (University of Utah School of Medicine), as well as the reappointment of Jean-Venable R. Goode, PharmD (Virginia Commonwealth University) to the 2025-2026 NFID Board of Directors, for 3-year terms through June 2028.
Wilbur H. Chen, MD, MS, is the Frank M. Calia, MD Endowed Professor of Medicine, chief of the division of geographic medicine, and director of travel medicine practice at the University of Maryland School of Medicine. He is also chief of the adult clinical studies section at the University of Maryland Center for Vaccine Development and Global Health. A physician-scientist who trained in adult infectious diseases, his career has covered the development and use of vaccines to address global health problems. He was a voting member of the Advisory Committee on Immunization Practices (ACIP) from 2020-2024. His academic research has focused on vaccines against diarrheal diseases, Campylobacter, Shigella, Cryptosporidium, salmonella, and Clostridioides difficile (C. diff). He also has extensive clinical research experience on vaccines against influenza, meningococcal disease, and biodefense agents, including anthrax, smallpox, tularemia, and staphylococcal enterotoxin. Chen has served on the planning committee of the NFID Clinical Vaccinology Course since 2019 and as an NFID speaker on travel vaccines. “I look forward to joining the NFID Board and collaborating with partners to advocate for vaccine programs and improved control and mitigation of diseases through vaccination,” said Chen.
Audrey M. Stevenson, PhD, MPH, FNP-BC, is a faculty member of the graduate nurse practitioner and master of public health programs at the University of Utah School of Medicine and an associate faculty member in the family nurse practitioner program at the University of Phoenix College of Nursing. An independent family nurse practitioner and consultant, she has been recognized and awarded for her work in vaccine advocacy. She formerly was the division director of family health and clinical services of the Salt Lake County Health Department and served on the Utah Vaccine Advisory Committee setting state vaccine policy. During the COVID-19 pandemic, she directed vaccination strategies for 1.2 million residents of Salt Lake County. Now retired from clinical practice, she continues to be a vaccine champion. Stevenson holds masters of public health and nursing degrees and received her doctorate in public health from the University of Utah. “NFID is on the cutting-edge of education and awareness,” Stevenson said. “I believe NFID and partners can use our voices to demonstrate the need for continued vigilance on important infectious disease issues, including antimicrobial resistance, vaccine programs, disease monitoring, and the vital education provided to healthcare professionals and the public.”
Jean-Venable (Kelly) R. Goode, PharmD, is professor and director of the Community-Based Pharmacy Residency Program at Virginia Commonwealth University. She is a credentialed community-based pharmacist practitioner at Daily Planet Health Services, a federally qualified health center that provides services to anyone regardless of their housing or insurance status. She developed innovative pharmacist patient care programs within a patient-centered medical home, including providing leadership for the Vaccines for Children and Vaccines for Adult Programs. Goode is the American Pharmacists Association liaison to ACIP and a former president of the American Pharmacists Association and Virginia Pharmacists Association. “The biggest challenge we face today is vaccine misinformation,” said Goode. “NFID is positioned to address this challenge through community partnerships, education, and consistent messaging to empower pharmacists and other healthcare professionals to engage with patients and address their concerns with evidence-based information, 1 individual at a time.”
The NFID Board of Directors also expresses appreciation to outgoing Director Kathleen H. Harriman, PhD, MPH, RN (California Department of Public Health) for her contributions to NFID.
As the governing body of NFID, the 2025-2026 NFID Board of Directors establishes the NFID strategic direction, ensures that annual goals are met, and provides financial oversight.
2025-2026 NFID Board of Directors
- Kevin A. Ault, MD (NFID Vice President), Western Michigan University Homer Stryker MD School of Medicine
- Oliver T. Brooks, MD, Charles R. Drew University of Medicine and Science
- Wilbur H. Chen, MD, MS, University of Maryland School of Medicine
- Marla Dalton, PE, CAE, NFID CEO (Ex-Officio)
- Monica M. Farley, MD (NFID President-Elect), Emory University School of Medicine
- Jeffery A. Goad, PharmD, MPH (NFID President), Chapman University School of Pharmacy
- Jean-Venable R. Goode, PharmD, Virginia Commonwealth University
- Robert H. Hopkins, Jr., MD, NFID Medical Director (Ex-Officio)
- Orin S. Levine, PhD, Tin Horse LLC
- Julie Morita, MD, The Joyce Foundation
- Flor M. Muñoz, MD, MSc, Baylor College of Medicine
- Kathleen M. Neuzil, MD, MPH (Federal Liaison)
- Sean T. O’Leary, MD, MPH, University of Colorado Denver Anschutz Medical Campus
- Kevin M. Rooney (NFID Secretary-Treasurer), NervGen Pharma
- Audrey M. Stevenson, PhD, MPH, FNP-BC, University of Utah School of Medicine
- Patricia A. Stinchfield, RN, MS, CPNP (NFID Immediate Past-President)
- Matthew M. Zahn, MD, OC Health Care Agency
About the National Foundation for Infectious Diseases
Founded in 1973, the National Foundation for Infectious Diseases (NFID) is a non-profit 501(c)(3) organization dedicated to educating and engaging the public, communities, and healthcare professionals about infectious diseases across the lifespan. NFID has a 4-star rating from Charity Navigator and has earned a Platinum transparency seal from Candid/GuideStar. Visit www.nfid.org for additional information.
Contact: Diana Olson, communications@nfid.org
Recent Press Releases
Medical Experts Urge Pregnant Women and Families to Talk with a Trusted Healthcare Professional about Respiratory Disease Prevention
Amid evolving and sometimes conflicting vaccine guidance, NFID kicks off its Respiratory Season News Briefing Series to help families facing tough decisions about their health
10/1/25 News Briefing: Respiratory Disease in Children and Pregnant Women
NFID will host the first in a series of 2025-2026 Respiratory Season News Briefings
Statement on September 2025 Advisory Committee on Immunization Practices Meeting
NFID strongly supports the use of evidence-based guidance to inform public health policy and will work to preserve equitable access, choice, and public and private insurance coverage to life-saving immunizations to protect the health of people across the US …